Calidi Biotherapeutics (CLDI) Invested Capital (2022 - 2024)

Calidi Biotherapeutics' Invested Capital history runs 3 years deep, the most recent figure standing at $223000.0 for Q4 2024.

• In Q4 2024, Invested Capital changed N/A year-over-year to $223000.0; the TTM figure through Sep 2025 stood at $223000.0 (down 64.77% YoY), while the FY2024 annual figure was $223000.0, changed N/A from the prior year.
• Invested Capital for Q4 2024 stood at $223000.0, up from $217000.0 in the prior quarter.
• The five-year high for Invested Capital was $1.0 million in Q4 2022, with the low at $205000.0 in Q1 2024.
• The 3-year median for Invested Capital is $220000.0 (2024), against an average of $476000.0.
• Peak annual rise in Invested Capital reached 78.3% in 2024, while the deepest fall reached 78.3% in 2024.
• Calidi Biotherapeutics' Invested Capital stood at $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then sank by 77.7% to $223000.0 in 2024.
• Business Quant data shows CLDI's Invested Capital at $223000.0 in Q4 2024, $217000.0 in Q3 2024, and $211000.0 in Q2 2024.